Literature DB >> 30936618

(Pseudo) "Exclusive" Contracts: An Insidious Business Practice that Selectively Damages IR.

Gerald A Niedzwiecki1.   

Abstract

Contracting is an important part of running the business of private practice interventional radiology. A basic knowledge of contracting is vital for the practicing interventionalist to best position him or herself to excel in private practice. Exclusive contracts are common in interventional, diagnostic, and radiology practices. Such contracts, however, may significantly limit the practice of individual interventional radiologists and impede the growth of interventional procedures in communities at large. This article outlines the role of exclusive contracts in interventional practices, and describes the limitations of such contracts.

Keywords:  contracts; interventional radiology; legal; private practice

Year:  2019        PMID: 30936618      PMCID: PMC6440904          DOI: 10.1055/s-0039-1679947

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  5 in total

1.  2000 RSNA annual oration in diagnostic radiology: The future of interventional radiology.

Authors:  G J Becker
Journal:  Radiology       Date:  2001-08       Impact factor: 11.105

2.  The birth, early years, and future of interventional radiology.

Authors:  Josef Rösch; Frederick S Keller; John A Kaufman
Journal:  J Vasc Interv Radiol       Date:  2003-07       Impact factor: 3.464

3.  The 2004 Dr. Charles T. Dotter Lecture: Interventional Radiology Today--What Would Charles Dotter Say?

Authors:  Anne C Roberts
Journal:  J Vasc Interv Radiol       Date:  2004-12       Impact factor: 3.464

4.  The 2007 Charles T. Dotter Lecture--our rock and our hard place: getting beyond competition to collaboration.

Authors:  Michael D Dake
Journal:  J Vasc Interv Radiol       Date:  2008-04-28       Impact factor: 3.464

5.  Endovascular stent grafts: the beginning of the future, or the beginning of the end?

Authors:  B T Katzen
Journal:  J Vasc Interv Radiol       Date:  1996 Jul-Aug       Impact factor: 3.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.